Inventor
ANTON MARIA SORAYA CARRANCIO
US8 patents
Patents
8 patentsUS11726080B2Aug 15, 2023
Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile
CELGENE CORP1 citations71
US11666579B2Jun 6, 2023
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
CELGENE CORP2 citations71
US12510533B2Dec 30, 2025
Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile
CELGENE CORP0 citations61
US12178822B2Dec 31, 2024
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dion
CELGENE CORP0 citations60
US12103923B2Oct 1, 2024
Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
CELGENE CORP0 citations60
US11390617B2Jul 19, 2022
Methods of treating non-Hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
CELGENE CORP1 citations60
US12396995B2Aug 26, 2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use
CELGENE CORP0 citations57
US11583536B2Feb 21, 2023
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use
CELGENE CORP0 citations57